TrialBreast cancer research and treatment2018

A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial.

Cesar A Santa-Maria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.